Skip Navigation

helen hobbs, md

Helen Hobbs, MD

 

 

 

 

Expert on Non-alcoholic Fatty Liver Disease (NAFLD) to speak on November 29

 

MEND Division Research Conference Series:

Nature, Nurture and NAFLD

Thursday, November 29, 2012
4:00-5:00 P.M.
Palmer Commons, University of Michigan
Forum Hall, 4th Floor
100 Washtenaw Ave., Ann Arbor 48109
Map & Directions

Helen Hobbs, M.D.
UT Southwestern Medical Center

Professor, University of Texas Southwestern
Philip O'Bryan Montgomery Jr., M.D., Distinguished
    Chair in Developmental Biology
Eugene McDermott Distinguished Chair for the
    Study of Human Growth and Development
Eugene McDermott Center for Human Growth &
    Development; Dept. of Internal Medicine;
Division of Molecular Genetics
Howard Hughes Medical Institute Investigator

Co-sponsored by the Michigan Metabolomics & Obesity Center,
the Division of Metabolism, Endocrinology & Diabetes (MEND),
and the Life Sciences Institute

Questions: Annette Murphy, (734) 763-3056 or amurph@umich.edu

Helen H. Hobbs, M.D., is an investigator of the Howard Hughes Medical Institute and a Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. She was born in Boston and obtained her undergraduate degree in human biology from Stanford University, prior to attending Case Western Reserve University School of Medicine. After completing an internship in internal medicine at Columbia-Presbyterian Medical Center, Dr. Hobbs moved to Dallas, Texas, where she finished her clinical training and served as chief resident in internal medicine at Parkland Memorial Hospital.

Dr. Hobbs worked as a postdoctoral fellow in the laboratory of Drs. Michael Brown and Joseph Goldstein before joining the faculty of UT Southwestern in 1987. She is director of the McDermott Center for Human Growth and Development, which serves as the Center for Human Genetics at UT Southwestern.  She is also director of the Dallas Heart Study, a longitudinal, multiethnic, population-based study of Dallas County. Her work focuses on defining the genetic determinants of plasma lipoprotein levels and cardiovascular risk. Most recently, she has focused on the genetic susceptibility to fatty liver disease.

She is a member of the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine, the American Academy of Arts and Sciences and the National Academy of Sciences. Dr. Hobbs received the the American Heart Association Clinical Research Prize, the Heinrich Wieland Prize and the 2007 American Heart Association Distinguished Scientist Award.